Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Profile neighbors
ELAVL1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP49 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
WDR37 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SNHG3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors
EIF3M - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PYGM - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
LOC100506548 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
LEPROT - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ZFX - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
DIDO1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
AOC3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
FUBP1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
ARPP19 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on